Palantir technologies expands fda partnership with $44m contract

Denver--(business wire)--palantir technologies inc. (nyse:pltr) announced today it was awarded a $44.4m, three-year contract with the u.s. food and drug administration (fda). the contract will build on palantir's existing partnership with the fda by providing an enterprise data management and analytics solution for the center for drug evaluation and research (cder) and the oncology center of excellence (oce), amongst their other technology investments. this contract represents palantir's larges
PLTR Ratings Summary
PLTR Quant Ranking